Newman Michael James
SEC CIK 1876315 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INDP | Indaptus Therapeutics, Inc. | CSO, Dir, 10% | 101.1K | — | $100.0K | 2 | 2022-01-31 | 2025-12-22 |
Most active insiders at INDP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ben-Tzvi Avraham | Dir | — | — |
| 2 | Newman Michael James | CSO, Dir | — | — |
| 3 | Sassi Nir | CFO | — | — |
| 4 | Linscott Walt Addison | COO | — | — |
| 5 | Meckler Jeffrey A | Co-CEO, Dir, 10% | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-29 | 2025-12-22 | INDP | Indaptus Therapeutics, Inc. | Newman Michael James | CSO, Dir | A - Grant | $2.03 | +52.2K | 101.1K | +107% | +$106.0K | |
| MI | 2022-02-02 | 2022-01-31+ | INDP | Indaptus Therapeutics, Inc. | Newman Michael James | CSO, Dir, 10% | S - Sale | $5.00 | -20.0K | 1.37M | -1% | -$100.0K |
Purchase Sale Sale after option exercise All abbreviations